Transaction · 0001878313-26-000099

Smith Stan

Smith Stan, DIR, reported a transaction classified as grant at MAIA Biotechnology, Inc. involving 38871.000000 shares for an estimated $0.00. Reported holdings after the transaction were 38871.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
MAIAMAIA Biotechnology, Inc.
Filing timeOct 02
Trade dateSep 30, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.19
Pre-filing
1mo ago +10.1%1w ago +10.9%1d ago -4.2%
Returns since
7d30d90d180d1y

MAIA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MAIA since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001878313-26-000099
Stock Options
Transaction date
Sep 30, 2026
Filed Oct 02, 2026, 08:18 PM · 2d delay
Shares
38.8k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
38.8k sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Large Holdings Increase
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of th…

  2. F2

    These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Original filing · 0001878313-26-000099
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MAIA